NO20066029L - Formuleringer som er stabile gjennom overgang fra hydrofobisk vehikkel til hydrofilt medium - Google Patents

Formuleringer som er stabile gjennom overgang fra hydrofobisk vehikkel til hydrofilt medium

Info

Publication number
NO20066029L
NO20066029L NO20066029A NO20066029A NO20066029L NO 20066029 L NO20066029 L NO 20066029L NO 20066029 A NO20066029 A NO 20066029A NO 20066029 A NO20066029 A NO 20066029A NO 20066029 L NO20066029 L NO 20066029L
Authority
NO
Norway
Prior art keywords
formulations
transition
stable
hydrophilic medium
carrier
Prior art date
Application number
NO20066029A
Other languages
English (en)
Norwegian (no)
Inventor
Michael A Desjardin
Gunjan Junnarkar
Kui Liu
Zengji Li
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/017914 external-priority patent/WO2005115333A2/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20066029L publication Critical patent/NO20066029L/no

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20066029A 2004-05-25 2006-12-27 Formuleringer som er stabile gjennom overgang fra hydrofobisk vehikkel til hydrofilt medium NO20066029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57466204P 2004-05-25 2004-05-25
PCT/US2005/017914 WO2005115333A2 (en) 2004-05-25 2005-05-23 A biomolecule-containing formulation of increased stability

Publications (1)

Publication Number Publication Date
NO20066029L true NO20066029L (no) 2007-02-16

Family

ID=37946531

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20066029A NO20066029L (no) 2004-05-25 2006-12-27 Formuleringer som er stabile gjennom overgang fra hydrofobisk vehikkel til hydrofilt medium

Country Status (3)

Country Link
CN (1) CN1960746A (zh)
NO (1) NO20066029L (zh)
ZA (1) ZA200610762B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ591810A (en) 2008-09-17 2012-12-21 Chiasma Inc Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid
EP3158342B1 (en) * 2014-06-19 2020-09-09 Life Technologies Corporation Method incorporating solid buffer
US10238709B2 (en) 2015-02-03 2019-03-26 Chiasma, Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Also Published As

Publication number Publication date
CN1960746A (zh) 2007-05-09
ZA200610762B (en) 2009-02-25

Similar Documents

Publication Publication Date Title
TW200611712A (en) Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
BRPI0616071B8 (pt) métodos de revestir uma micropartícula cristalina pré-formada em suspensão com um agente ativo
NO20073559L (no) Nanopartiklulaere tacrolimus-formuleringer
NO20062741L (no) Surfaktantbasert gel som en injiserbar, vedvarende leveringsvehikkel
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
ATE531368T1 (de) Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
BR0108449A (pt) Formulações de pasta aperfeiçoada
BRPI0708282A8 (pt) Método para determinar um valor limite dinâmico e método para formatar uma faixa de células dentro
EP4233843A3 (en) Antibody compositions
NO20066029L (no) Formuleringer som er stabile gjennom overgang fra hydrofobisk vehikkel til hydrofilt medium
JP2009516717A5 (zh)
DK1866414T3 (da) Inhibitorer af ribonukleotidreduktase-underenhed 2 og anvendelser deraf.
NO20043257D0 (no) Innkapslede bindingsproteiner som biosensorer
NO20055747L (no) Stabile, vandige losninger av human erytropoietin som ikke inneholder serumalbumin
TW200636025A (en) Light stabilizer emulsion composition
WO2005021706A3 (en) Delivery of compounds with rehydrated blood cells
WO2007075827A3 (en) Homogeneous paste formulations
EA201070378A1 (ru) Фармацевтические составы орлистата
DE60122302D1 (de) Polymer-masse
ATE407674T1 (de) Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
WO2006013391A3 (en) Conformable structures
BRPI0514378A (pt) composições seladoras e obturantes liberadoras de gás
TW200616611A (en) Stable particle formulations of erythropoietin receptor agonists
CO6450645A2 (es) Emulsiones nutritivas con un contenido elevado de fibra que comprenden glicerina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application